Showing results (171-180 of 134,544) with videos related to
Sort By:
Pageof 13,455
Organic Letters|July 14, 2006
Design of Brønsted acid-assisted chiral Brønsted acid catalyst bearing a bis(triflyl)methyl group for a Mannich-type reactionAiko Hasegawa, Yuki Naganawa, Makoto Fushimi, et al.Journal of Biomedical Materials Research|February 1, 1997
Enhanced strength in cemented stem fixation using adhesive acrylic cement as a metal coating materialS Morita, H Yamamoto, K Furuya, et al.Biomed Research International|January 24, 2014
Changes in the mucus barrier during cisplatin-induced intestinal mucositis in ratsHajime Yamamoto, Kazuhiko Ishihara, Yuko Takeda, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 7, 1998
[Clinical evaluation of fundic gland polyps and hyperplastic polyps]A Yamamoto, M Ichikawa, O Takahara, et al.Chirality|January 10, 2003
New bulky chiral Lewis acid catalyst: 3,3'-di(2-mesitylethynyl)binaphthol-titanium(IV) complexKazuaki Ishihara, Jun Kobayashi, Kazuhiko Nakano, et al.Journal of Chromatography. A|October 20, 2005
Rational methods for predicting human monoclonal antibodies retention in protein A affinity chromatography and cation exchange chromatography. Structure-based chromatography design for monoclonal antibodiesTakashi Ishihara, Toshihiko Kadoya, Hideaki Yoshida, et al.[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|January 28, 2021
Five-year disease-related risk of mortality in ambulatory frail older JapaneseAyumi Kono, Naomi Fukushima, Takuma Ishihara, et al.Journal of Nutritional Science and Vitaminology|November 2, 2018
Validity of Estimated Acrylamide Intake by the Dietary Record Method and Food Frequency Questionnaire in Comparison with a Duplicate Method: A Pilot StudyJunpei Yamamoto, Junko Ishihara, Ayaka Kotemori, et al.Hepato-Gastroenterology|September 23, 2011
Hepatectomy for hepatocellular carcinoma in patients with severe thrombocytopeniaShogo Tanaka, Kanji Ishihara, Chie Watanabe, et al.Rinsho Shinkeigaku = Clinical Neurology|September 1, 1995
[The high-dose gamma-globulin therapy for inflammatory demyelinating peripheral neuropathy: evaluations of clinical effects and serum IgG subclasses]H Ishihara, K Kondou, F Sofue, et al.Pageof 13,455